MediPines Advantage
Triage Location
Risk stratify patients with MediPines AGM100, a pulmonary gas exchange monitor, by categorizing mild (send home), moderate (admit-observe) to severe (admit-treatment).
Hospital
Monitor response to therapy (in hospital care) with objective pulmonary gas exchange measurements. Categorize respiratory patients from severe to critical: Does the patient need ventilator access?
Long Term Care Facility
Monitor impending respiratory risks with MediPines AGM100, a respiratory monitor. Pulmonary gas exchange measurements for residents 1-3 times per day with a simple 2-minute respiratory test can help health workers in long-term care facilities monitor respiratory conditions such as COPD or other respiratory illnesses
Key Advantages
-
Objective, non-invasive pulmonary gas exchange test, in under 2 minutes.
-
Rapid assessment of patients’ respiratory status.
-
Objective early assessment and rapid clinical decision making.
-
Reduced pathogen exposure to front line healthcare workers.
-
Portable system, high patient compliance, intuitive push button operation.
-
Strong scientific foundation, extensive clinical evidence.
-
Backed by the top 2 of the 10 largest hospital systems in the United States.
Key Benefits Highlighted by Current Adoptees
-
Dramatic reduction in hospitalized COVID-19 patient death rates.
-
Significant reduction in ICU/Ventilator uses and PPE needs.
-
High boost in healthcare worker morale.
-
Radical operating leverage in limited resource situations.
-
One MediPines AGM100 test cost is at a fraction of current PPE costs.
